Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier A CALYM Study

Overview of attention for article published in The Journal of Molecular Diagnostics, October 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 9 news stories from 8 outlets.

THURSDAY, Oct. 19, 2017 (HealthDay News) -- A novel gene expression profiling diffuse large B-cell lymphoma (DLBCL) classifier…

Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (n…

Diffuse large B-cell lymphoma (DLBCL), an aggressive cancer is the most frequently diagnosed non-Hodgkin lymphoma worldwide…

Medicine, Health Care New Assay May Boost Targeted… Published: October 17, 2017.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 5 additional news stories.